Biogen gains $20B in value on new hope for Alzheimer's drug By: Boston Business Journal via Business Journals November 04, 2020 at 11:47 AM EST FDA advisors say in documents released Wednesday that they find Biogen's drug data “robust and exceptionally persuasive.” Read More >>